IP Library › Assignment 064277/0523
Patent Assignment
Reel/Frame 064277/0523

Assignment of Assignor's Interest

Recorded: 2023-07-17 Pages: 6
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Substituted [1,2,4]Triazolo[1,5-a]Pyrimidines and Their Use as Potassium Channel Modulators
Patent: 8,685,987 →
Application: 13/258,944 →
Publication: US 2012/0101112
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 23, 2011
From: SORENSEN, ULRIK SVANE; ERIKSEN, BIRGITTE L.; HOUGAARD, CHARLOTTE; STROBAEK, DORTE
To: NEUROSEARCH A/S
Reel/Frame 027276/0183 →
Assignment of Assignor's Interest Mar 20, 2013
From: NEUROSEARCH A/S
To: ANIONA APS
Reel/Frame 030049/0894 →
Assignment of Assignor's Interest Aug 6, 2013
From: ANIONA APS
To: ATAXION, INC.
Reel/Frame 030946/0329 →
Merger Jul 17, 2023
From: ATAXION, INC.
To: LUC THERAPEUTICS, INC.
Reel/Frame 064277/0494 →
Change of Name Jul 17, 2023
From: LUC THERAPEUTICS, INC.
To: CADENT THERAPEUTICS, INC.
Reel/Frame 064277/0542 →